While other reviews have described the MACE risk reduction in the general population with T2DM [23, 24], non-T2DM [25], or both [26], the present study seeks to address the gap in the literature in providing a comprehensive meta-analysis on the number need to treat (NNT), efficacy and safety profile of GLP-1RA in reducing the risk of myocardial infarction (MI) and individual ASCVD constituents, namely non-fatal MI, unstable angina, coronary revascularization, and/or cardiovascular mortality
Adipogenic changes of hepatocytes in a highfat dietinduced fatty liver mice model and nonalcoholic fatty liver disease patients
Best practice: Take thyroid medication on an empty stomach, space supplements appropriately, and recheck labs after starting GLP-1 therapy if you are losing substantial weight and discuss with your treating physician
2026 03 18 glutatin y cncer Llus Espinosa EN Llus Espinosa Coordinator of the Research Group on Molecular Mechanisms of Cancer and Stem Cells at IMIM-Hospital del Mar The study by Hecht and colleagues is impeccably conducted, and its experimental rigour allows for a solid demonstration of the importance of extracellular glutathione as a source of cysteine in breast tumours, at least in the murine models analysed